To Your Health
Nudging the FDA

There’s a better way between the contending libertarian and paternalist approaches to regulating drugs.

Appeared in: Volume 10, Number 2 | Published on: October 17, 2014
W. Nicholson Price II is assistant professor at the University of New Hampshire School of Law, where he writes on innovation and regulation in the life sciences. I. Glenn Cohen is professor, Harvard Law School, and director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. His next book is New and Enduring Challenges for FDA: Selected Essays on the Future of the Agency and its Regulation of Drugs and New Technologies (co-edited with Holly Fernandez Lynch), forthcoming in 2015 from Columbia University Press.
We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.
© The American Interest LLC 2005-2024
About Us Privacy
We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.